AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23672956
Drug: Intramuscular hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intramuscular hydrocortisone (100 mg)
Trial: 19434784
Drug: Topical provocation
RxNorm normalized name: OCTINOXATE 0.072 g in 1 g TOPICAL LIPSTICK [EFFET PARFAIT ROUGE AMPLIFIER AMPLIFYING SPF 15 (ROUGE PROVOCATION) - RED]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical provocation with 15 mg GSTS
Trial: 10770199
Drug: L-[3-13C1]sodium lactate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-[3-13C1]sodium lactate and D-[6,6-D2]glucose infusion
Trial: 9354211
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg pentazocine i.v.
Trial: 9354211
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg tilidine i.v.
Trial: 28005113
Drug: Tablet questionnaires
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet questionnaires
Trial: 25858478
Drug: Colestyramine 4
RxNorm normalized name: Colestyramine 4 g powder for oral suspension sachet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestyramine 4 g twice daily
Trial: 23565660
Drug: Oral combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral combined vitamins for 1 year
Trial: 15231980
Drug: Azithromycin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (10 mg/kg on day 1 and 5 mg/kg on days 2-5)
Trial: 15231980
Drug: Erythromycin estolate
RxNorm normalized name: Erythromycin Estolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin estolate (40 mg/kg/day in 3 divided doses for 10 days)
Trial: 2517679
Drug: Glucose (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (group G)
Trial: 29033560
Drug: Proactive palliative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive palliative care in monthly meetings with a specialized palliative care team (SPCT)
Trial: 26149129
Drug: Rosuvastatin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 2.5 mg/day
Trial: 24452168
Drug: PCR testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCR testing with concurrent antistaphylococcal antibiotics
Trial: 22952075
Drug: Oral tropisetron
RxNorm normalized name: tropisetron
DrugBank: Tropisetron (DB11699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tropisetron at 5 mg/day
Trial: 22952075
Drug: Oral tropisetron
RxNorm normalized name: tropisetron
DrugBank: Tropisetron (DB11699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tropisetron at 10 mg/day
Trial: 22952075
Drug: Oral tropisetron
RxNorm normalized name: tropisetron
DrugBank: Tropisetron (DB11699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tropisetron at 20 mg/day
Trial: 20937929
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestin (CEE plus medroxyprogesterone acetate 2.5 mg/d)
Trial: 10805061
Drug: Flosequinan 50
RxNorm normalized name: flosequinan 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flosequinan 50 mg
Trial: 10805061
Drug: Flosequinan 100
RxNorm normalized name: flosequinan 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flosequinan 100 mg
Trial: 10805061
Drug: Flosequinan 150
RxNorm normalized name: Flosequinan
DrugBank: Flosequinan (DB13228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flosequinan 150 mg
Trial: 7685176
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg captopril twice a day
Trial: 27626622
Drug: Sertraline, 100
RxNorm normalized name: Sertraline, 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline, 100 mg/d for 24 weeks
Trial: 20695007
Drug: 4.5mg nightly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5mg nightly naltrexone (low-dose naltrexone, LDN)
Trial: 19029083
Drug: 0-50 ng/mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0-50 ng/mL rhVEGF(165) for 7 days in vitro
Trial: 19029083
Drug: 0 or
RxNorm normalized name: K-10 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 or 50 ng/mL rhVEGF(165) for one hour prior to implantation
Trial: 16179956
Drug: NMR pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NMR pulse sequences; treatment duration: 9 days
Trial: 12706694
Drug: Intramuscular vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vaccination (3 doses of 25 microg of protein each, with 6 weeks interval and a third dose after 10 months)
Trial: 12706694
Drug: Intranasal vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal vaccination (4 weekly doses followed by a fifth dose after 5 months, each dose consisting of OMVs equivalent to 250 microg of protein)
Trial: 8678499
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg THP vesical irrigation
Trial: 8678499
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg THP vesical irrigation
Trial: 22681244
Drug: Daily dosing
RxNorm normalized name: Osmolex 322 MG Daily Dosing Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dosing prophylaxis
Trial: 22681244
Drug: Standard prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard prophylactic dosing regimen
Trial: 16186372
Drug: Intravitreal injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injection (IVI) of 4 mg triamcinolone acetonide (TA)
Trial: 16186372
Drug: Sub-Tenon's infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sub-Tenon's infusion (STi) of 40 mg triamcinolone acetonide (TA)
Trial: 14578254
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IGT and NCEP definitions
Trial: 14578254
Drug: NCEP definition
RxNorm normalized name: ESIKA PRO HD COLOR HIGH DEFINITION COLOR SPF 20 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NCEP definition with fasting glucose >or=5.4 mmol/l
Trial: 10947341
Drug: Zanamivir treatment
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanamivir treatment (bid)
Trial: 10947341
Drug: Zanamivir treatment
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanamivir treatment (qid)
Trial: 10947341
Drug: Zanamivir treatment
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanamivir treatment (bid and qid)
Trial: 8777296
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (omeprazole, amoxycillin, and bismuth)
Trial: 8777296
Drug: Loxiglumide (LOX)
RxNorm normalized name: Dexloxiglumide
DrugBank: Dexloxiglumide (DB04856)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loxiglumide (LOX) administration after Hp eradication
Trial: 1806610
Drug: Calcium (calcium
RxNorm normalized name: Slow-Mag with Calcium (calcium carbonate 298 MG (calcium 119 MG) / magnesium chloride 596 MG (magnesium 71.5 MG)) Delayed Release Oral Tablet, Reformulated Feb 2012
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (calcium carbonate with meals to attain an intake of 1,700 mg daily)
Trial: 6749443
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of methylprednisolone sodium succinate given intravenously every six hours for seven days
Trial: 6749443
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg of methylprednisolone sodium succinate given intravenously every six hours for seven days
Trial: 31348579
Drug: Nivolumab 240
RxNorm normalized name: nivolumab 240 MG in 24 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab 240 mg at 2-week intervals
Trial: 21863237
Drug: PX-12 administered
RxNorm normalized name: PX-12
DrugBank: PX-12 (DB05448)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PX-12 administered at 400 mg/m(2)/day by 72-hour infusion
Trial: 23561002
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg ibuprofen (IBUg)
Trial: 21525198
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg riboflavin for 8 weeks
Trial: 21525198
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg riboflavin for 8 weeks
Trial: 9117838
Drug: Topical streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical streptokinase
Trial: 8478851
Drug: Suprascapular nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suprascapular nerve block using steroid/bupivacaine
Trial: 24917198
Drug: Pregnenolone (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregnenolone (titrated to 500 mg/day)
Trial: 22532639
Drug: Continuous NSAID
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous NSAID treatment
Trial: 22532639
Drug: On-demand NSAID
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand NSAID treatment
Trial: 22532639
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (continuous and on-demand)
Trial: 20360277
Drug: Psychiatric advance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychiatric advance directives (PADs) documenting medication preferences
Trial: 20360277
Drug: Being prescribed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Being prescribed at least one medication requested in the psychiatric advance directive
Trial: 19670189
Drug: Sirolimus (SRL)
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus (SRL) therapy
Trial: 18585837
Drug: Calcineurin-inhibitor (CNI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcineurin-inhibitor (CNI) therapy (Control)
Trial: 12934178
Drug: Indinavir/ritonavir (Idv/Rtv;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir/ritonavir (Idv/Rtv; 800/100 mg 2 times daily)
Trial: 12934178
Drug: Saquinavir/ritonavir (Sqv/Rtv;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir/ritonavir (Sqv/Rtv; 1000/100 mg 2 times daily)
Trial: 10800876
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg salbutamol and 500 microg ipratropium
Trial: 10800876
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg salbutamol
Trial: 24641586
Drug: Cholecalciferol 10,000
RxNorm normalized name: CHOLECALCIFEROL 10,000UNIT TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 10,000 IU weekly, titrated up to 50,000 IU weekly if necessary
Trial: 22564753
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of fenofibrate per each hemodialysis day for 4 weeks
Trial: 17671159
Drug: L‐BLP25 (peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐BLP25 (peptide vaccine)
Trial: 9445297
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (BUD)
Trial: 2133623
Drug: 20 mmol
RxNorm normalized name: dibasic potassium phosphate 120 MMOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mmol Mg‐aspartate‐HCl/d for 3 months
Trial: 17080543
Drug: Both acupuncture
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both acupuncture and physical therapy
Trial: 11557462
Drug: Tenofovir DF
RxNorm normalized name: LAMIVUDINE 300MG/TENOFOVIR DF 300MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenofovir DF 75 mg
Trial: 11557462
Drug: Tenofovir DF
RxNorm normalized name: LAMIVUDINE 300MG/TENOFOVIR DF 300MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenofovir DF 150 mg
Trial: 11557462
Drug: Tenofovir DF
RxNorm normalized name: LAMIVUDINE 300MG/TENOFOVIR DF 300MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenofovir DF 300 mg
Trial: 11557462
Drug: Tenofovir DF
RxNorm normalized name: LAMIVUDINE 300MG/TENOFOVIR DF 300MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenofovir DF 600 mg
Trial: 7841749
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no immunosuppressive agents)
Trial: 3074295
Drug: Low protein
RxNorm normalized name: Low protein mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low protein diet with standard antihypertensive therapy
Trial: 3074295
Drug: Captopril administration
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril administration (25‐50 mg/day) for 4 weeks
Trial: 31704275
Drug: Transcranial infrared
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial infrared brain stimulation (TIBS), a form of photobiomodulation (PBM), details on dosage and duration not available.
Trial: 31315657
Drug: Probiotic mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic mixture (Ecologic® Barrier; 2.5 × 10^9 colony forming units/g; 2 g; daily)
Trial: 29191799
Drug: Web-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based intervention website addressing barriers to organ donation through videos; no specific dosage or duration mentioned.
Trial: 29191799
Drug: Web-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based intervention website; no specific dosage or duration mentioned.
Trial: 21368061
Drug: No concurrent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No concurrent motor execution (baseline)
Trial: 16810002
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine (0.05 mg . kg(‐1) . h(‐1), approximately 3 mg/h)
Trial: 15502035
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of hyperbaric bupivacaine 0.5% (n = 20)
Trial: 15502035
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of hyperbaric levobupivacaine 0.5% (n = 20)
Trial: 15502035
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg of hyperbaric ropivacaine 0.5% (n = 20)
Trial: 11676331
Drug: Triple-drug regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-drug regimen (lansoprazole, clarithromycin, secnidazole)
Trial: 11676331
Drug: Quadruple-drug regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple-drug regimen (lansoprazole, amoxycillin, colloidal bismuth subcitrate, secnidazole)
Trial: 9634207
Drug: Anti-retroviral treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-retroviral treatment (Zidovudine)
Trial: 19042322
Drug: Cognitive-behaviorally-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behaviorally-based treatment for AOSUD
Trial: 12036665
Drug: Evening dosing
RxNorm normalized name: Evening Dosing 24 HR Jornay 60 MG Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening dosing of latanoprost 0.005%/timolol maleate 0.5%
Trial: 12036665
Drug: Morning dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dosing of latanoprost 0.005%/timolol maleate 0.5%
Trial: 12036665
Drug: Timolol maleate
RxNorm normalized name: Timolol Maleate
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol maleate given twice daily
Trial: 12036665
Drug: Evening dosing
RxNorm normalized name: Evening Dosing 24 HR Jornay 60 MG Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening dosing of latanoprost/timolol
Trial: 7972188
Drug: Inpatient accommodation
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient accommodation for oncology patients receiving radiotherapy treatment
Trial: 2689909
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose morphinic administered for induction and maintenance of anesthesia without further analgesic and/or narcotic supplement.
Trial: 769772
Drug: L-dopa (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-dopa (up to 1250 mg daily)
Trial: 30835911
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human soluble thrombomodulin (rhTM) at a dosage of 380 U/kg/day for 6 days
Trial: 30835911
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (control arm)
Trial: 28817370
Drug: Gemcitabine 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1,000 mg/m2 days 1, 8, 15, every 4 weeks plus erlotinib 100 mg once per day (GemErlo)
Trial: 24041815
Drug: Saccharomyces boulardii
RxNorm normalized name: Saccharomyces boulardii
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saccharomyces boulardii 50 mg/kg every 12 h
Trial: 16753687
Drug: 1 IOVE
RxNorm normalized name: Ioversol
DrugBank: Ioversol (DB09134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1 IOVE capsule per day (Group 1; n = 562)
Trial: 16753687
Drug: 2 IOVE
RxNorm normalized name: Ioversol
DrugBank: Ioversol (DB09134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 2 IOVE capsules per day (Group 2; n = 518)
Trial: 15484298
Drug: Oxymatrine capsule
RxNorm normalized name: Oxymatrine
DrugBank: Oxymatrine (DB16276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymatrine capsule (group A)
Trial: 11777288
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg orally daily)
Trial: 11777288
Drug: Ranitidine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (50 mg intravenously four times daily)
Trial: 30614286
Drug: Lidocaine plaster
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine plaster (700 mg)
Trial: 24863037
Drug: 1.4% LSO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.4% LSO gel
Trial: 21078493
Drug: anti-dsDNA antibodies
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: anti-dsDNA antibodies
Trial: 21078493
Drug: antinucleosome antibodies
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antinucleosome antibodies
Trial: 21078493
Drug: anti-C1q antibodies
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: anti-C1q antibodies
Trial: 16941030
Drug: Celecoxib, 400
RxNorm normalized name: Celecoxib, 400 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib, 400 mg b.i.d.
Trial: 16941030
Drug: Diclofenac, 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac, 75 mg b.i.d.
Trial: 16941030
Drug: Ibuprofen, 800
RxNorm normalized name: Ibuprofen, 800 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen, 800 mg three times a day.
Trial: 1489126
Drug: Inhaled furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled furosemide (28 mg)
Trial: 1489126
Drug: Inhaled torasemide
RxNorm normalized name: torasemide
DrugBank: Torasemide (DB00214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled torasemide (28 mg)
Trial: 30646197
Drug: Manual therapy/individualized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy/individualized exercise
Trial: 24561636
Drug: 5-week neck
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-week neck strengthening intervention performed twice per week
Trial: 10087420
Drug: Doxium (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxium (calcium dobesilate) 2 g daily until delivery
Trial: 2333739
Drug: Formula with
RxNorm normalized name: Stress B Formula with C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula with 1.3 g protein/dl and 55:45 whey: casein ratio
Trial: 2333739
Drug: Formula with
RxNorm normalized name: Stress B Formula with C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula with 1.4 g/dl protein; 55:45 whey: casein ratio
Trial: 2333739
Drug: Formula with
RxNorm normalized name: Stress B Formula with C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula with 1.5 g/dl protein; 55:45 whey: casein ratio
Trial: 2333739
Drug: Formula with
RxNorm normalized name: Stress B Formula with C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula with 1.4 g/dl protein; 60:40 whey: casein ratio
Trial: 2333739
Drug: Formula with
RxNorm normalized name: Stress B Formula with C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula with 1.4 g/dl protein; 20:80 whey: casein ratio
Trial: 2333739
Drug: All formulas
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All formulas containing 0.7 mg iron and 0.7 mg zinc/dl
Trial: 453775
Drug: Prazosin (Pz)
DrugBank: Prazosin (DB00457)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prazosin (Pz) 2 mg t.i.d.